With manufacturing now underway in preparation for commercialization, Myrtelle is accelerating toward its goal of delivering the first approved therapy for Canavan disease, opening a new chapter in ...

With manufacturing now underway in preparation for commercialization, Myrtelle is accelerating toward its goal of delivering the first approved therapy for Canavan disease, opening a new chapter ...

"This is a transformative moment for Myrtelle and the entire Canavan disease community," said Adrian Stecyk, Chief Executive Officer of Myrtelle . "Initiating commercial manufacturing represents ...

Engineered with a unique tropism for oligodendrocytes—the myelin-producing cells compromised in Canavan disease—MYR-101 is designed to directly address the genetic root of the disorder by ...

Dr. Evan Goldstein, an NYC-based anal surgeon, cautions about a warning sign that can increase the risk of getting diagnosed with a "silent disease." ...

As ticks migrate to new regions due to milder winters and habitat changes, experts warn about the increase of diseases such as Lyme disease, alpha-gal syndrome and tick paralysis.

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson's disease and a way to modify it, paving the way for future ...

The genetic disease harlequin ichthyosis affects the transport of fats within the skin, resulting in hard, scalelike plaques and an array of other symptoms.